Catalent Greenville, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1240 Sugg Parkway, Greenville, North Carolina (NC) 27834, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3000209735 · DUNS 118812386
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-10-24
- NAIDrug Quality Assurance2024-01-31
- VAIDrug Quality Assurance2019-07-12
- NAIBioresearch Monitoring2018-08-24
- NAIDrug Quality Assurance2017-04-13
- NAIDrug Quality Assurance2016-07-14
- NAIDrug Quality Assurance2014-05-02
- NAIBioresearch Monitoring2013-08-21
- VAIDrug Quality Assurance2012-05-11
- VAIDrug Quality Assurance2011-03-18
- VAIDrug Quality Assurance2010-10-01
- NAIDrug Quality Assurance2009-11-13
Drugs this plant is listed as making
10 distinct drugs across 14 products name this site in their FDA label.
- abiraterone acetateSun Pharmaceutical Industries, Inc.
- chlorzoxazoneMayne Pharma Commercial LLC
- doxycycline hyclateMayne Pharma Commercial LLC
- ItraconazoleMayne Pharma Commercial LLC
- mavorixaforX4 Pharmaceuticals, Inc.
- Methamphetamine HydrochlorideMayne Pharma Commercial LLC
- olutasidenibRigel Pharmaceuticals, Inc.
- ponatinib hydrochlorideTakeda Pharmaceuticals America, Inc.
- Tamoxifen CitrateMayne Pharma Commercial LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.